References
- Bachmann G A, Leiblum S R. The impact of hormones on menopausal sexuality: a literature review. Menopause 2004; 11: 120–130
- Nappi R E, Polatti F. The use of estrogen therapy in women's sexual functioning. J Sex Med 2009; 6: 603–616
- Pastore L M, Carter R A, Hulka B S, Wells E. Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative. Maturitas 2004; 49: 292–303
- Lindau S T, Schumm L P, Laumann E O, Levinson W, O'Muircheartaigh C A, Waite L J. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357: 762–774
- Nappi R E. New attitudes to sexuality in the menopause: clinical evaluation and diagnosis. Climacteric 2007; 10(Suppl 2)105–108
- Levine K B, Williams R E, Hartmann K E. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 2008; 15: 661–666
- Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002; 77: S42–S48
- Shifren J L, Monz B U, Russo P A, Segreti A, Johannes C B. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112: 970–978
- Manolis A, Doumas M. Sexual dysfunction: the ‘prima ballerina’ of hypertension-related quality-of-life complications. J Hypertens 2008; 26: 2074–2084
- McCall-Hosenfeld J S, Freund K M, Legault C, et al. Sexual satisfaction and cardiovascular disease: the Women's Health Initiative. Am J Med 2008; 121: 295–301
- Munarriz R, Kim N N, Goldstein I, Traish A M. Biology of female sexual function. Urol Clin North Am 2002; 29: 685–693
- Addis I B, Ireland C C, Vittinghoff E, Lin F, Stuenkel C A, Hulley S. Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol 2005; 106: 121–127
- Castelo-Branco C, Cancelo M J, Villero J, Nohales F, Julia M D. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas 2005; 52: S46–S52
- Long C Y, Liu C M, Hsu S C, Wu C H, Wang C L, Tsai E M. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women. Menopause 2006; 13: 737–743
- Al-Baghdadi O, Ewies A A. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 2009; 12: 91–105
- Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006; 4: CD001500
- Kendall A, Dowsett M, Folkerd E, Smith I. Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006; 17: 584–587
- Rioux J E, Devlin C, Gelfand M M, Steinberg W M, Hepburn D S. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000; 7: 156–161
- Dugal R, Hesla K, Sordal T, Aase K H, Lilleeidet O, Wickstrom E. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 2000; 79: 293–297
- Simon J, Nachtigall L, Gut R, Lang E, Archer D F, Utian W. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet. Obstet Gynecol 2008; 112: 1053–1060
- Bachmann G, Lobo R A, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008; 111: 67–76
- Weisberg E, Ayton R, Darling G, et al. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 2005; 8: 83–92
- North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 2007; 14: 355–369